News And Insights
The Trump Era – Defining the Next Four Years of Healthcare
The past 18 months have been nothing short of dramatic, from Clinton’s historic win of the Democratic nomination to, of course, Trump’s win of the 2016 election. Time and time
Pricing and pharma’s reputation, how deep does it go?
Pharma and its appearance have always been an issue of contention. This is particularly the case when references are made to specialized drugs that are used to treat correspondingly specialized
Leveraging the Untapped Patient Pool
As pharmaceutical companies growth starts to plateau and drug discovery becomes more and more challenging, the industry is looking at ways in which to continue to maintain profitability whilst growing
How Disruptive are Biosimilars, Really?
Biologics have gained immense popularity over the past decade; in 2014, four of the top five best selling drugs globally were biologics. Their efficacy has been proven for various diseases
Does Pharma Need a Digital Makeover?
We have watched technology rapidly revolutionize several global industries. While the healthcare sector is generally slow to absorb radical trends, we have begun seeing its effects here. For example, the
Lavni Varyani, Founder and Principal Consultant is interviewed by The Learning Curve – Podcasts for Women Entrepreneurs in the Middle East
Listen to her interview – http://goo.gl/fP8WA0 Read the article – http://goo.gl/yWCpsQ